Latest Almitas Capital LLC Stock Portfolio
$240Million– No. of Holdings #75
Almitas Capital LLC Performance:
2024 Q2: -0.73%YTD: -0.84%2023: 0.02%
Performance for 2024 Q2 is -0.73%, and YTD is -0.84%, and 2023 is 0.02%.
About Almitas Capital LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Almitas Capital LLC reported an equity portfolio of $240.5 Millions as of 30 Jun, 2024.
The top stock holdings of Almitas Capital LLC are , , . The fund has invested 11.2% of it's portfolio in BLACKROCK HEALTH SCIENCES TERM TRUST and 6.7% of portfolio in NUVEEN CORE PLUS IMPACT FUND.
The fund managers got completely rid off GREAT AJAX CORP (AJX) and FIRST TRUST ENERGY INFRASTRUCTURE FUND stocks. They significantly reduced their stock positions in DWS MUNICIPAL INCOME TRUST and GREAT AJAX CORP (AJX). Almitas Capital LLC opened new stock positions in ATEA PHARMACEUTICALS INC (AVIR), BLACKROCK INNOVATION AND GROWTH TERM TRUST and AMYLYX PHARMACEUTICALS INC (AMLX). The fund showed a lot of confidence in some stocks as they added substantially to CLOUGH GLOBAL OPPORTUNITIES FUND and DESIGN THERAPEUTICS INC (DSGN).
The top stock holdings of Almitas Capital LLC are , , . The fund has invested 11.2% of it's portfolio in BLACKROCK HEALTH SCIENCES TERM TRUST and 6.7% of portfolio in NUVEEN CORE PLUS IMPACT FUND.
The fund managers got completely rid off GREAT AJAX CORP (AJX) and FIRST TRUST ENERGY INFRASTRUCTURE FUND stocks. They significantly reduced their stock positions in DWS MUNICIPAL INCOME TRUST and GREAT AJAX CORP (AJX). Almitas Capital LLC opened new stock positions in ATEA PHARMACEUTICALS INC (AVIR), BLACKROCK INNOVATION AND GROWTH TERM TRUST and AMYLYX PHARMACEUTICALS INC (AMLX). The fund showed a lot of confidence in some stocks as they added substantially to CLOUGH GLOBAL OPPORTUNITIES FUND and DESIGN THERAPEUTICS INC (DSGN).
Almitas Capital LLC Equity Portfolio Value
Last Reported on: 15 Aug, 2024
Almitas Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Almitas Capital LLC made a return of -0.73% in the last quarter. In trailing 12 months, it's portfolio return was -1.12%.
New Buys
| Ticker | $ Bought |
|---|---|
| atea pharmaceuticals inc | 4,270,520 |
| blackrock innovation and growth term trust | 3,927,670 |
| amylyx pharmaceuticals inc | 3,617,320 |
| western asset investment grade defined opportunity trust inc | 3,575,440 |
| western asset global corporate defined opportunity fund inc | 2,475,250 |
| virtus convertible & income 2024 target term fund | 2,449,140 |
| acelyrin inc | 1,658,670 |
| blackrock municipal 2030 target term trust | 1,607,430 |
New stocks bought by Almitas Capital LLC
Additions
| Ticker | % Inc. |
|---|---|
| clough global opportunities fund | 386 |
| alliancebernstein national municipal income fund | 265 |
| tortoise energy infrastructure corp | 157 |
| bny mellon strategic municipal bond fund inc | 144 |
| mainstay mackay definedterm municipal opportunities fund | 122 |
| dws strategic municipal income trust | 111 |
| blackrock health sciences term trust | 89.27 |
| blackrock esg capital allocation term trust | 84.49 |
Additions to existing portfolio by Almitas Capital LLC
Reductions
| Ticker | % Reduced |
|---|---|
| dws municipal income trust | -87.16 |
| calamos long/short equity & dynamic income trust | -87.07 |
| pimco energy & tactical credit opportunities fund | -83.57 |
| nuveen new jersey quality municipal income fund | -79.54 |
| blackrock california municipal income trust | -64.4 |
| great ajax corp | -63.09 |
| two harbors investment corp | -48.19 |
| morgan stanley emerging markets domestic debt fund inc | -47.05 |
Almitas Capital LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| great ajax corp | -22,260,700 |
| john hancock tax-advantaged global shareholder yield fund | -2,820,730 |
| first trust energy infrastructure fund | -7,584,360 |
| first trust energy income and growth fund | -6,332,930 |
| first trust mlp and energy income fund | -2,045,370 |
| first trust new opportunities mlp & energy fund | -707,370 |
| western asset inflation-linked opportunities & income fund | -730,452 |
| abrdn national municipal income fund | -805,076 |
Almitas Capital LLC got rid off the above stocks
Sector Distribution
Almitas Capital LLC has about 93.2% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 93.2 |
| Healthcare | 5.7 |
| Real Estate | 1.1 |
Market Cap. Distribution
Almitas Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 93.2 |
| MICRO-CAP | 6.3 |
Stocks belong to which Index?
About 5.6% of the stocks held by Almitas Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 94.4 |
| RUSSELL 2000 | 5.6 |
Almitas Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Almitas Capital LLC
Almitas Capital LLC has 75 stocks in it's portfolio. About 52.3% of the portfolio is in top 10 stocks. DSGN proved to be the most loss making stock for the portfolio. NKTR was the most profitable stock for Almitas Capital LLC last quarter.
Last Reported on: 15 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AJX | great ajax corp | 0.68 | 456,181 | 1,628,570 | reduced | -63.09 | ||
| AJX | great ajax corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMLX | amylyx pharmaceuticals inc | 1.50 | 1,903,850 | 3,617,320 | new | |||
| AVIR | atea pharmaceuticals inc | 1.78 | 1,290,190 | 4,270,520 | new | |||
| DSGN | design therapeutics inc | 1.75 | 1,253,250 | 4,198,380 | added | 22.14 | ||
| NKTR | nektar therapeutics | 0.47 | 920,225 | 1,141,080 | unchanged | 0.00 | ||
| NYMT | new york mortgage trust inc | 0.45 | 185,139 | 1,081,210 | unchanged | 0.00 | ||
| RLYB | rallybio corp | 0.06 | 100,876 | 135,174 | new | |||
| SPRB | spruce biosciences inc | 0.09 | 396,506 | 205,271 | new | |||
| TWO | two harbors investment corp | 0.65 | 1,613,000 | 1,567,170 | reduced | -48.19 | ||
| blackrock health sciences term trust | 11.25 | 1,761,940 | 27,063,400 | added | 89.27 | |||
| nuveen core plus impact fund | 6.68 | 1,475,810 | 16,056,800 | reduced | -8.15 | |||
| blackrock esg capital allocation term trust | 6.12 | 839,103 | 14,717,900 | added | 84.49 | |||
| nuveen pennsylvania quality municipal income fund | 6.00 | 1,183,330 | 14,436,600 | added | 22.51 | |||
| miller/howard high dividend fund | 5.16 | 1,105,960 | 12,397,900 | added | 16.41 | |||
| nuveen preferred & income term fund | 4.06 | 501,903 | 9,762,010 | added | 83.89 | |||
| mainstay mackay definedterm municipal opportunities fund | 3.45 | 500,407 | 8,296,750 | added | 122 | |||
| pgim short duration high yield opportunities fund | 3.36 | 526,474 | 8,070,850 | added | 17.29 | |||
| tortoise midstream energy fund inc | 3.23 | 180,717 | 7,761,800 | added | 34.72 | |||
| eaton vance new york municipal bond fund | 2.99 | 730,155 | 7,199,330 | reduced | -9.48 | |||